US News

U.S. CDC advisers back J&J COVID-19 vaccine benefits amid neurological illness reports

Published by

(Reuters) – Despite reports of a rare neurological disorder appearing in some people who have received Johnson & Johnson’s COVID-19 vaccine, the benefits of its use outweigh the risks, a U.S. Centers for Disease Control and Prevention advisory panel said on Thursday. The U.S. Food and Drug Administration last week added a warning to its fact sheet for J&J’s single-shot vaccine saying that data suggests there is an increased risk of Guillain-BarreĢ syndrome (GBS) in the six weeks after vaccination. The CDC advisory panel evaluated the J&J vaccine’s risks and benefits after these preliminary rep…

Read More

Facebook Comments

Check Also

Watch: Judge Orders Bailiff To Remove Maskless Top Dallas Official From Meeting

Watch: Judge Orders Bailiff To Remove Maskless Top ...